Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Bibliographic Details
Main Author:	Pierre Miossec
Format:	Article
Language:	English
Published:	AVES Yayincilik 2020-08-01
Series:	European Journal of Rheumatology
Online Access:	https://www.eurjrheumatol.org/en/understanding-the-cytokine-storm-during-covid-19-contribution-of-preexisting-chronic-inflammation-133312

Similar Items

COVID-19: In the Eye of the Cytokine Storm
by: Roberto de la Rica, et al.
Published: (2020-09-01)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

Worsening of Preexisting Psychiatric Conditions During the COVID-19 Pandemic
by: Susanna Gobbi, et al.
Published: (2020-12-01)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
by: Mingshan Jiang, et al.
Published: (2021-01-01)

Controlling Cytokine Storm Is Vital in COVID-19
by: Lu Tang, et al.
Published: (2020-11-01)

Cytokine storm in COVID-19 and the treatment simulacrum
by: Anita Karimi, et al.
Published: (2020-01-01)

Immunotherapy Summary for Cytokine Storm in COVID-19
by: Yaqun Li, et al.
Published: (2021-09-01)

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
by: Antonella Fara, et al.
Published: (2020-09-01)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
by: Angela E. Peter, et al.
Published: (2021-01-01)

The signal pathways and treatment of cytokine storm in COVID-19
by: Lan Yang, et al.
Published: (2021-07-01)

Candesartan could ameliorate the COVID-19 cytokine storm
by: Abdel G. Elkahloun, et al.
Published: (2020-11-01)

Cytokine storm in COVID-19: Potential therapeutics for immunomodulation
by: Md Mohosin Rana
Published: (2020-09-01)

COVID-19: more than a cytokine storm
by: Giovanni Riva, et al.
Published: (2020-09-01)

A glimpse into the eye of the COVID-19 cytokine storm
by: Krutika Kuppalli, et al.
Published: (2020-05-01)

Reversible Taste Loss in a COVID-19 Patient With Preexisting Chronic Smell Impairment
by: Hadar Klein BSc, et al.
Published: (2021-02-01)

Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review
by: Quirch, Miguel, et al.
Published: (2020-08-01)

Thromboembolism after COVID-19 vaccine in patients with preexisting thrombocytopenia
by: Alessandro Mauriello, et al.
Published: (2021-08-01)

Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms
by: Khan MA, et al.
Published: (2021-01-01)

How COVID-19 induces cytokine storm with high mortality
by: Shintaro Hojyo, et al.
Published: (2020-10-01)

On the role of bacterial metalloproteases in COVID-19 associated cytokine storm
by: László Földvári-Nagy, et al.
Published: (2021-01-01)

Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
by: Luigi Brunetti, et al.
Published: (2020-09-01)

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
by: Yujun Tang, et al.
Published: (2020-07-01)

Cytokine storm in severe patient COVID-19 and curative plasmapheresis
by: Victoria Rusu
Published: (2021-09-01)

Correction: The signal pathways and treatment of cytokine storm in COVID-19
by: Lan Yang, et al.
Published: (2021-08-01)

Possible ameliorative effect of colchicine on the prevention of cytokine storm and its associated hyper-inflammation in patients with COVID-19
by: Bijan Keikhaei, et al.
Published: (2020-01-01)

Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm
by: Michel Desjarlais, et al.
Published: (2020-12-01)

Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes.
by: Ilja L Kruglikov, et al.
Published: (2021-02-01)

Fatal pulmonary fibrosis complicating COVID-19 infection in preexistent emphysema
by: Massimiliano Mazzolini, MD, et al.
Published: (2021-02-01)

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections
by: Kenneth E. Remy, et al.
Published: (2021-02-01)

Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
by: Steven Douedi, et al.
Published: (2020-01-01)

Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients
by: Hui Guo, et al.
Published: (2020-10-01)

Covid-19 cytokine storm in pulmonary tissue: Anatomopathological and immunohistochemical findings
by: Anna Flavia Ribeiro dos Santos Miggiolaro, et al.
Published: (2020-01-01)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
by: Annette Langer-Gould, et al.
Published: (2020-10-01)

The COVID-19 Cytokine Storm; What We Know So Far
by: Dina Ragab, et al.
Published: (2020-06-01)

Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
by: Yi Miao, et al.
Published: (2020-06-01)

Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia
by: Yvon Ruch, et al.
Published: (2020-07-01)

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
by: Ruirong Chen, et al.
Published: (2021-04-01)

Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
by: Jayanta Talukdar, et al.
Published: (2020-12-01)

Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
by: Luke Y.C. Chen, et al.
Published: (2021-05-01)

A research update: Significance of cytokine storm and diaphragm in COVID-19
by: Ashwani Mittal, et al.
Published: (2021-01-01)